Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bolis

Showing results (51-60 of 129) with videos related to

Pageof 13
Sort By:
Seminars in Oncology|February 1, 1997
A phase I trial with fixed-dose carboplatin and escalating doses of paclitaxel in advanced ovarian cancerG Bolis, G Scarfone, A Villa, et al.
Tumori|December 31, 1983
The role of surgery in gestational trophoblastic diseaseG Bolis, C Belloni, F Vergadoro, et al.
Tumori|July 25, 1998
[Guidelines for epithelial ovarian tumor]G Bolis, A Zappalà, A Villa, et al.
European Journal of Cancer|May 1, 1979
K cell activity in ovarian cancer patients given chemotherapyA Mantovani, N Polentarutti, P Gritti, et al.
Tumori|April 30, 1986
Thyroid function in gestational trophoblastic tumorsF Vergadoro, L Tabacchi, P Barbacini, et al.
Tumori|December 10, 1999
A phase I-II trial of high-dose ifosfamide in patients with ovarian cancer refractory or resistant to platinum and/or paclitaxel-containing chemotherapyG Scarfone, A Villa, F Parazzini, et al.
Acta Obstetricia Et Gynecologica Scandinavica|July 1, 1993
Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomasP Vercellini, L Bocciolone, A Colombo, et al.
Tumori|February 28, 1985
The value of endometrial cytology in a high risk populationE Buratti, F Cefis, M Masserini, et al.
Gynecologic Oncology|September 1, 1987
Tumor antigen CA 125 as a marker of ovarian epithelial carcinomaF Zanaboni, F Vergadoro, M Presti, et al.
Cancer Treatment Reports|May 1, 1982
Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancerC Sessa, M D'Incalci, I Valente, et al.
Pageof 13

Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
Seminars in Oncology|February 1, 1997
A phase I trial with fixed-dose carboplatin and escalating doses of paclitaxel in advanced ovarian cancerG Bolis, G Scarfone, A Villa, et al.
Tumori|December 31, 1983
The role of surgery in gestational trophoblastic diseaseG Bolis, C Belloni, F Vergadoro, et al.
Tumori|July 25, 1998
[Guidelines for epithelial ovarian tumor]G Bolis, A Zappalà, A Villa, et al.
European Journal of Cancer|May 1, 1979
K cell activity in ovarian cancer patients given chemotherapyA Mantovani, N Polentarutti, P Gritti, et al.
Tumori|April 30, 1986
Thyroid function in gestational trophoblastic tumorsF Vergadoro, L Tabacchi, P Barbacini, et al.
Tumori|December 10, 1999
A phase I-II trial of high-dose ifosfamide in patients with ovarian cancer refractory or resistant to platinum and/or paclitaxel-containing chemotherapyG Scarfone, A Villa, F Parazzini, et al.
Acta Obstetricia Et Gynecologica Scandinavica|July 1, 1993
Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomasP Vercellini, L Bocciolone, A Colombo, et al.
Tumori|February 28, 1985
The value of endometrial cytology in a high risk populationE Buratti, F Cefis, M Masserini, et al.
Gynecologic Oncology|September 1, 1987
Tumor antigen CA 125 as a marker of ovarian epithelial carcinomaF Zanaboni, F Vergadoro, M Presti, et al.
Cancer Treatment Reports|May 1, 1982
Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancerC Sessa, M D'Incalci, I Valente, et al.
Pageof 13